Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00422799 · OUTCOME

Duration of Response in Patients With WM

Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM) · Source last updated 2020-10-27

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
years
Interval / dispersion
95% Confidence Interval
Time frame
5 Years

What was measured

Time from documentation of first response to progressive disease.

Analysis population: All participants enrolled

Groups in this outcome

Bortezomib and Rituximab

bortezomib and rituximab Bortezomib: Once weekly for 3 weeks Rituximab: Intravenously once a week for the first and fourth weeks of a cycle

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Bortezomib and Rituximab63

Reported measurements

Source class 1
Values in years · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Bortezomib and Rituximab1.4Not reported0.65Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.6
        upper Limit
        5
        value
        1.4
denoms
  1. counts
    1. group Id
      OG000
      value
      63
    units
    Participants
description
Time from documentation of first response to progressive disease.
dispersion Type
95% Confidence Interval
groups
  1. description
    bortezomib and rituximab Bortezomib: Once weekly for 3 weeks Rituximab: Intravenously once a week for the first and fourth weeks of a cycle
    id
    OG000
    title
    Bortezomib and Rituximab
param Type
MEDIAN
population Description
All participants enrolled
reporting Status
POSTED
time Frame
5 Years
title
Duration of Response in Patients With WM
type
SECONDARY
unit Of Measure
years

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice